how do we treat gej carcinoma resistant to her2 targeted therapies?
Published 1 year ago • 33 plays • Length 1:15Download video MP4
Download video MP3
Similar videos
-
3:03
targeted therapies for gastroesophageal adenocarcinoma
-
3:12
advances in her2-targeted therapies for gastric cancer
-
0:59
sequencing her2-targeted therapies in breast cancer
-
0:54
targeted treatment for gastric cancer beyond her2
-
28:57
evolution of her2-targeted therapy in gastroesophageal adenocarcinoma
-
28:57
for pharmacists: evolution of her2-targeted therapy in gastroesophageal adenocarcinoma
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
0:24
her2-targeting adcs for urothelial carcinoma
-
35:36
personalized treatment of advanced her2-negative gastric or gastroesophageal junction cancer
-
3:18
pangea: personalized treatment strategy for patients with metastatic gastroesophageal adenocarcinoma
-
2:01
the latest developments in targeted therapies for breast cancer
-
2:15
treatment strategies for her2 metastatic breast cancer
-
1:23
recent advances in the use of targeted therapies for metastatic urothelial carcinoma
-
2:22
sequencing therapies in her2 breast cancer
-
1:43
gasther2: trastuzumab for advanced gastric cancer
-
5:46
use of her2-targeted therapy in breast cancer
-
1:37
consolidative radiotherapy for oligometastatic her2-negative esophageal and gastric adenocarcinoma.
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer
-
2:29
mountaineer: tucatinib plus trastuzumab for her2 metastatic colorectal cancer